prostate radiotherapy

RADIATION2 trials

Sponsors

UNICANCER, Fudan University

Conditions

Adenocarcinoma of ProstateMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Metastatic Prostate CancerProgression of Prostate CancerProstate Cancer (Adenocarcinoma)

Phase 2

CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer

Not yet recruitingNCT07268794

Fudan UniversityMetastatic Hormone-Sensitive Prostate Cancer (mHSPC), Metastatic Prostate Cancer, Prostate Cancer (Adenocarcinoma)

Start: 2025-11-30End: 2027-12-30Target: 112Updated: 2025-12-08

Phase 3

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

Active, not recruitingNCT01952223

UNICANCERAdenocarcinoma of Prostate, Progression of Prostate Cancer

Start: 2013-12-31End: 2041-07-31Updated: 2025-07-30

Related Papers

A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse.

Journal of Clinical Oncology2014-05-206 citations